133 related articles for article (PubMed ID: 24305748)
21. Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists.
van den Berg J; Hamel CC; Coppus SF; Snijders MP; Vandenbussche FP
J Obstet Gynaecol; 2019 Oct; 39(7):1006-1011. PubMed ID: 31215270
[TBL] [Abstract][Full Text] [Related]
22. [Association of mifepristone and misoprostol for the medical management of early pregnancy failure].
Bouschbacher L; Maatouk A; Collin P; Welter E; Morel O; de Malartic CM
Gynecol Obstet Fertil; 2014 Dec; 42(12):832-7. PubMed ID: 25458806
[TBL] [Abstract][Full Text] [Related]
23. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.
Shaw KA; Shaw JG; Hugin M; Velasquez G; Hopkins FW; Blumenthal PD
Contraception; 2015 Apr; 91(4):313-9. PubMed ID: 25499589
[TBL] [Abstract][Full Text] [Related]
24. Early pregnancy termination with mifepristone and misoprostol in Norway.
Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
[TBL] [Abstract][Full Text] [Related]
25. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
Chung T; Leung P; Cheung LP; Haines C; Chang AM
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
[TBL] [Abstract][Full Text] [Related]
26. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
Heikinheimo O; Leminen R; Suhonen S
Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
[TBL] [Abstract][Full Text] [Related]
27. Medical management of miscarriage: Predictive factors of success.
Lusink V; Wong C; de Vries B; Ludlow J
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):590-593. PubMed ID: 29624638
[TBL] [Abstract][Full Text] [Related]
28. Association between uterine position and transvaginal misoprostol treatment for early pregnancy failure.
Chill HH; Malyanker N; Karavani G; Haj-Yahya R; Herzberg S; Bahar R; Shveiky D; Dior UP
J Obstet Gynaecol Res; 2018 Feb; 44(2):248-252. PubMed ID: 29094502
[TBL] [Abstract][Full Text] [Related]
29. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
Nisand I; Bettahar K;
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213
[TBL] [Abstract][Full Text] [Related]
30. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death.
Sharma D; Singhal SR; Poonam ; Paul A; Kunika
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):322-5. PubMed ID: 22030047
[TBL] [Abstract][Full Text] [Related]
31. The role of repeat misoprostol dose in the management of early pregnancy failure.
Rottenstreich A; Levin G; Ben Shushan A; Yagel S; Porat S
Arch Gynecol Obstet; 2019 Nov; 300(5):1287-1293. PubMed ID: 31422461
[TBL] [Abstract][Full Text] [Related]
32. Medical management of early pregnancy loss with mifepristone and misoprostol in emergency departments compared to a Complex Family Planning office: Implementation of a COVID-19 institutional policy change.
Bleck RR; Danvers AA; Nimbvikar A; Gurney EP
Contraception; 2024 Aug; 136():110467. PubMed ID: 38641155
[TBL] [Abstract][Full Text] [Related]
33. A comparison of medical management with misoprostol and surgical management for early pregnancy failure.
Zhang J; Gilles JM; Barnhart K; Creinin MD; Westhoff C; Frederick MM;
N Engl J Med; 2005 Aug; 353(8):761-9. PubMed ID: 16120856
[TBL] [Abstract][Full Text] [Related]
34. Medication abortion.
Bartz D; Goldberg A
Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
[TBL] [Abstract][Full Text] [Related]
35. Medical management of early pregnancy failure: how to treat and what to expect.
Dempsey A; Davis A
Semin Reprod Med; 2008 Sep; 26(5):401-10. PubMed ID: 18825608
[TBL] [Abstract][Full Text] [Related]
36. Acceptability and feasibility of medical abortion in Nepal.
Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
38. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
[TBL] [Abstract][Full Text] [Related]
39. Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
Roe AH; Abernathy A; Flynn AN; McAllister A; Koelper NC; Sammel MD; Schreiber CA; Sonalkar S
Obstet Gynecol; 2022 Jun; 139(6):1149-1151. PubMed ID: 35675613
[TBL] [Abstract][Full Text] [Related]
40. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
